Treatment of Spontaneous Isolated Superior Mesenteric Artery Dissection in Hemodynamically Stable Patients Without Mesenteric Ischemia

This protocol addresses the management of spontaneous isolated superior mesenteric artery (SMA) dissection in patients who are hemodynamically stable and present without clinical or radiological signs of rupture or mesenteric ischemia.

Clinical scenario

Hemodynamically stable
No clinical or imaging evidence of ruptured SMA dissection
No signs of mesenteric ischemia

An increasing number of patients with SMA dissection who are hemodynamically stable are being managed conservatively rather than with immediate surgical or endovascular intervention.

Approach

Conservative management forms the basis of treatment in this setting, involving bowel rest and anticoagulation as initial steps — with a structured transition to oral therapy and risk-factor control that follows a defined sequence. The complete regimen, including the specific agents used and the criteria for progression, is in the full protocol.

Treatment goals

Symptom resolution: settling of abdominal pain.
Radiological resolution: confirmed resolution of the SMA dissection on follow-up imaging.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.4070/kcj.2018.0429

An increasing number of patients with SMA dissection who are hemodynamically stable are treated conservatively.

These patients were hemodynamically stable and had no clinical or imaging evidence of ruptured SMA dissection.

Along with anticoagulation therapy (heparin drip or warfarin), conservative management includes antiplatelets like cilostazol and ticlopidine, bowel rest and control of risk factors like hypertension.

It is recommended to have complete bowel rest and administer intravenous heparin until the abdominal pain settles.

Oral anticoagulants and antiplatelet medications are continued until resolution of radiological images.

View source ↗